| 222 | 12 | 316 |
| 下载次数 | 被引频次 | 阅读次数 |
目的 比较单纯高强度聚焦超声(HIFU)与HIFU联合促性腺激素释放激素激动剂(GnRH-a)用于子宫肌瘤治疗的应用效果及安全性。方法 回顾性分析2022年8月至2023年1月北京协和医院聚焦超声消融治疗中心收治的120例接受HIFU治疗的子宫肌瘤患者的临床资料，根据治疗方式的不同进行分组：GnRH-a预处理联合HIFU治疗组(A组)36例、HIFU治疗后联合GnRH-a治疗组(B组)19例、单纯HIFU治疗组(C组)65例。于治疗后1、6、12个月分别评估子宫肌瘤体积、子宫肌瘤症状评分、血红蛋白水平等。结果 3组患者治疗前的一般情况(包括年龄、体质量指数、病灶体积等)比较无显著性差异(P>0.05)。A组的HIFU治疗总能量显著低于B组(P<0.05)。治疗后，3组患者的子宫肌瘤体积均显著缩小(P<0.05)、子宫肌瘤症状评分均显著降低(P<0.05)、血红蛋白水平均显著升高(P<0.05)。HIFU治疗后1个月，3组患者间子宫肌瘤症状评分、血红蛋白水平比较无显著性差异(P>0.05);HIFU治疗后6个月和12个月，A、B组的子宫肌瘤症状评分显著低于C组(P<0.05),血红蛋白水平显著高于C组(P<0.05)。HIFU治疗后12个月，C组有4例(6.15%)患者复发，A、B组无患者复发。3组均无HIFU相关的严重不良反应发生。结论 HIFU联合GnRH-a治疗子宫肌瘤是安全有效的，症状缓解率和子宫肌瘤缩小率有高于单独使用HIFU治疗的趋势，且复发率明显降低。
Abstract：Objective:To compare the therapeutic effects and safety of high-intensity focused ultrasound(HIFU) alone and HIFU combined with gonadotropin releasing hormone agonist(GnRH-a) in the treatment of uterine fibroids.Methods:A retrospective analysis was conducted on the clinical data of 120 patients with uterine fibroids who received HIFU treatment. Among them, 36 cases underwent pre-treatment of GnRH-a combined with HIFU(group A),and 19 cases were treated with GnRH-a after HIFU treatment(group B),65 cases were treated with HIFU alone(group C). Uterine fibroid volume, uterine fibroid symptom score, and hemoglobin(Hb) levels were assessed at 1,6,and 12 months after HIFU.Results:There were no significant differences in the age, body mass index and the volume of uterine fibroids among the three groups(P>0.05). The total therapeutic energy of group A was significantly lower than that of group B(P<0.05). After treatment, the volume of uterine fibroids in the three groups significantly decreased(P<0.05),the symptom score of uterine fibroids significantly decreased(P<0.05),and the Hb level significantly increased(P<0.05). One month after HIFU,there were no statistically significant differences in uterine fibroid symptom scores and Hb levels among the three groups(P>0.05). However, at 6 and 12 months after HIFU,the symptom scores of uterine fibroids in group A and B were significantly lower than that of group C(P<0.05),while Hb levels were significantly higher(P<0.05). At 12 months after HIFU,four patients in group C,while none in group A and B,experienced recurrence. No serious adverse reactions were found in the three groups.Conclusions:HIFU combined with GnRH-a can be effectively and safely applied in the treatment of uterine fibroids with the trend of higher symptom relief and uterine fibroid reduction rates as well as lower recurrence rate.
[1] 曹泽毅，乔杰主编.中华妇产科学[M].第2版.北京：人民卫生出版社，199:803.
[2] 子宫肌瘤的诊治中国专家共识专家组.子宫肌瘤的诊治中国专家共识[J].中华妇产科杂志，2017,52:793-800.
[3] 俞平娟.高强度聚焦超声治疗子宫黏膜下非带蒂肌瘤二例[J].中国医师杂志，2011,13:306-307.
[4] Vercellini P,Crosigaani PG,Mangioni C,et al.Treatment with a gonadotrophin releasing hormone agonist before hysterectomy for leiomyomas:results of a multicentre,randomised controlled trial[J].Br J Obstet Gynaecol,1998,105:1148-1154.
[5] Kroon B,Johnson N,Chapman M,et al.Fibroids in infertility consensus statement from ACCEPT(Australasian CREI Consensus Expert Panel on Trial evidence)[J].Aust N Z J Obstet Gynaecol,2011,51:289-295.
[6] 邹敏，邓勇斌，王智亮，等.高强度聚焦超声消融治疗子宫肌瘤后妊娠结局分析[J].中国超声医学杂志，2014,30:254-258.
[7] 张苗，周洪贵，田小兵.高强度聚焦超声在妇产科的临床应用[J/OL].中华临床医师杂志(电子版),2015,9:3096-3099.
[8] Smart OC,Hindley JT,Regan L,et al.Magnetic resonance guided focused ultrasound surgery of uterine fibroids - the tissue effects of GnRH agonist pre-treatment[J].Eur J Radiol,2006,59:163-167.
[9] Funaki K,Fukunishi H,Funaki T,et al.Magnetic resonance-guided focused ultrasound surgery for uterine fibroids:relationship between the therapeutic effects and signal intensity of preexisting T2-weighted magnetic resonance images[J].Am J Obstet Gynecol,2007,196:184.
[10] 蒋莉.HIFU联合GnRH-a治疗T2WI高信号子宫肌瘤的近远期效果研究[D].重庆：重庆医科大学，2023.
[11] 中国医师协会妇产科医师分会子宫内膜异位症专业委员会.子宫腺肌病诊治中国专家共识[J].中华妇产科杂志，2020,55:376-383.
[12] 杨振华，陈晓，高秀霞，等.高强度聚焦超声治疗胎盘植入一例[J].国际妇产科学杂志，2014,41:87-88.
[13] 许永华.MRI引导、监测和评估HIFU治疗子宫肌瘤研究[D].重庆：重庆医科大学，2014.
[14] 张亚丽.注射用缓释醋酸亮丙瑞林治疗子宫内膜异位症临床效果观察[J].中国继续医学教育，2018,10:120-122.
[15] 徐锋，镡丽霞，李盼，等.高强度聚焦超声消融联合GnRH-a治疗子宫腺肌病的临床研究[J].国际妇产科学杂志，2019,46:618-620,640.
[16] 任娟，桑学梅，刘艳，等.高强度聚焦超声联合亮丙瑞林治疗子宫腺肌病30例分析[J].安徽医药，2020,24:1381-1384.
[17] 张燕燕，刘桂香.不同术式对子宫腺肌瘤患者症状改善及卵巢功能影响的差异[J].广东医学，2011,32:1903-1905.
[18] 张莹莹，杨洁，肖国宏，等.盆腔手术及年龄对子宫内膜异位症患者辅助生殖妊娠结局的影响[J].生殖医学杂志，2018,27:243-247.
[19] Wang Y,Geng J,Bao H,et al.Comparative effectiveness and safety of high-intensity focused ultrasound for uterine fibroids:a systematic review and meta-analysis[J].Front Oncol,2021;11:600800.
[20] Yan L,Huang H,Lin J,et al.High-intensity focused ultrasound treatment for symptomatic uterine fibroids:a systematic review and meta-analysis[J].Int J Hyperthermia,2022,39:230-238.
[21] Zhang L,Rao F,Setzen R.High intensity focused ultrasound for the treatment of adenomyosis:selection criteria,efficacy,safety and fertility[J].Acta Obstet Gynecol Scand,2017,96:707-714.
[22] Park H,Yoon SW.Efficacy of single-dose gonadotropin-releasing hormone agonist administration prior to magnetic resonance-guided focused ultrasound surgery for symptomatic uterine fibroids[J].Radiol Med,2017,122:611-616.
[23] Lethaby A,Puscasiu L,Vollenhoven B.Preoperative medical therapy before surgery for uterine fibroids[DB/OL].Cochrane Database Syst Rev,2017,11:CD000547.
[24] Watanabe Y,Nakamura G,Matsuguchi H,et al.Efficacy of a low-dose leuprolide acetate depot in the treatment of uterine leiomyomata in Japanese women[J].Fertil Steril,1992,58:66-71.
[25] Szydlowska I,Grabowska M,Nawrocka-Rutkowska J,et al.Markers of cellular proliferation,apoptosis,estrogen/progesterone receptor expression and fibrosis in selective progesterone receptor modulator(ulipristal acetate)-treated uterine fibroids[J].J Clin Med,2021,10:562.
[26] Borahay MA,Asoglu MR,Mas A,et al.Estrogen receptors and signaling in fibroids:role in pathobiology and therapeutic implications[J].Reprod Sci,2017,24:1235-1244.
[27] Khan KN,Fujishita A,Koshiba A,et al.Expression profiles of E/P receptors and fibrosis in GnRHa-treated and -untreated women with different uterine leiomyomas[J/OL].PLoS One,2020,15:e0242246.
基本信息:
中图分类号:R737.33
引用信息:
[1]孙梦源,张国瑞,于昕.高强度聚焦超声消融联合促性腺激素释放激素激动剂治疗子宫肌瘤的临床疗效观察[J].生殖医学杂志,2024,33(08):1051-1057.
基金信息:
中央高水平医院临床科研专项(2022-PUMCH-C-046)
2024-08-15
2024-08-15